Revolution Medicines Inc (RVMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RVMD | ROIV | INCY | ||
| Company | Revolution Medicines Inc | Roivant Sciences Ltd | Incyte Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 96.54 | 27.25 | 91.00 | ||
| High | 97.37 | 27.97 | 93.83 | ||
| Low | 92.59 | 27.10 | 91.00 | ||
| Latest | 94.29 | 27.36 | 92.23 | ||
| Change | -1.23 | +0.49 | +1.61 | ||
| % Change | -1.29% | +1.82% | +1.78% | ||
| Volume | 2,483,600 | 3,286,400 | 1,055,700 | ||
| 20-Day Average Volume | 2,350,575 | 6,198,430 | 1,760,045 | ||
| Previous Close | 95.52 | 26.87 | 90.62 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 98.57 | 28.44 | 95.02 | ||
| 20-Day Raw Stochastic | 14.53% | 20.59% | 23.80% | ||
| 20-Day Relative Strength | 44.26 | 52.28 | 40.67 | ||
| Weighted Alpha | +98.36 | +170.82 | +40.11 | ||
| Today's Opinion | 40% Buy | 88% Buy | 24% Sell | ||
| Previous Opinion | 40% Buy | 88% Buy | 24% Sell | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 64% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.89% since 03/18/26 | -1.58% since 03/18/26 | -0.01% since 03/18/26 | ||
| Low | 92.59 on 03/25/26 | 26.59 on 03/24/26 | 89.25 on 03/24/26 | ||
| High | 100.07 on 03/19/26 | 28.39 on 03/23/26 | 93.83 on 03/25/26 | ||
| 1-Month | |||||
| %Chg | -8.67% since 02/25/26 | -4.54% since 02/25/26 | -7.75% since 02/25/26 | ||
| Low | 92.59 on 03/25/26 | 26.59 on 03/24/26 | 89.25 on 03/24/26 | ||
| High | 104.32 on 02/27/26 | 30.33 on 03/11/26 | 101.77 on 02/27/26 | ||
| 3-Month | |||||
| %Chg | +16.13% since 12/24/25 | +21.60% since 12/24/25 | -8.17% since 12/24/25 | ||
| Low | 76.28 on 01/05/26 | 20.78 on 01/05/26 | 89.25 on 03/24/26 | ||
| High | 124.49 on 01/16/26 | 30.33 on 03/11/26 | 112.29 on 01/07/26 | ||
| 6-Month | |||||
| %Chg | +121.81% since 09/25/25 | +82.89% since 09/25/25 | +12.94% since 09/25/25 | ||
| Low | 42.78 on 09/26/25 | 14.86 on 09/29/25 | 81.78 on 09/26/25 | ||
| High | 124.49 on 01/16/26 | 30.33 on 03/11/26 | 112.29 on 01/07/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 18,929,484 | 19,230,886 | 18,034,650 | ||
| Shares Outstanding, K | 198,173 | 715,701 | 199,014 | ||
| Annual Sales | 0 | 29,050,000 | 5,141,240,000 | ||
| Annual Net Income | -1,131,300,000 | -171,980,000 | 1,286,650,000 | ||
| Last Quarter Sales | 0 | 2,000,000 | 1,506,840,000 | ||
| Last Quarter Net Income | -364,890,000 | -265,890,000 | 299,280,000 | ||
| 60-Month Beta | 0.99 | 1.17 | 0.84 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.86 on 02/25/26 | -0.24 on 02/06/26 | 1.80 on 02/10/26 | ||
| Latest Earnings Date | 05/06/26 | 06/04/26 | 05/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 15.62 | ||